CTG Inc. will add approximately 300 jobs for its part in the recently announced UB-New York Genome Center initiative, a UB official said today.
It isn't yet clear where the employees will be sited - CTG will make use of the supercomputers at UB's Center for Computational Research on the Buffalo Niagara Medical Campus, but its headquarters are also a short ways away at 800 Delaware Ave.
The company expects to leverage the partnership to enhance its products in the healthcare IT world, specifically related to medical informatics.
"Our relationship with UB's CCR will differentiate CTG as we deliver new medical informatics products and services and help position us as an important emerging big data analytics company targeted to healthcare," said James Boldt, CTG's chairman and CEO.
The CTG jobs number is one of the first few hard details about the project, announced recently by Gov. Andrew Cuomo during his State of the State address. UB will be awarded $50 million in state money, most of which is expected to go for infrastructure improvements to its supercomputers, and the Manhattan-based Genome Center will receive a $55 million state allocation.
The center's research will be stored at UB's CCR - and a series of private companies will have access to the data to develop healthcare and IT-related products.
Empire Genomics and Personalized Medicine Pathways, both of which already have a presence on the medical campus, are involved in the project. Germany-based AESKU.Diagnostics and Utah-based Lineagen are involved as well and are currently finalizing details about where they'll lease space on the medical campus, said Marnie LaVigne, UB's associate vice president for economic development.
"We anticipate bringing in many more companies as well," LaVigne said. "It's the clustering idea that's very much based on the concept built into the Buffalo Billion plan."
CTG is one of the largest healthcare IT companies in the entire U.S. and has become a leader in bioinformatics computing and software, company officials have said. Nearly 400 of its 3,800 employees are currently located in Western New York.
The publicly traded company has seen an overall increase in its individual share prices over the past year, from $18.57 to $17.82.
It also has long history of medical campus projects and collaborations.
The company teamed up with UB to announce a $29 million project in 2009 to improve care and reduce costs for individuals with chronic kidney disease. As part of that project, CTG was to help develop an IT system making it easier to store and track disease-related records.
In 2010, Dell Inc., UB and CTG announced the creation of a new Institute for Healthcare Informatics, which is currently sited in UB's Roosevelt building at 923 Main St. on the medical campus.
CTG is also an important partner with Roswell Park Cancer Institute's new $23.6 million Center for Personalized Medicine. CTG played a major role in the center's development, pledging $2.5 million toward the project.